by DMCBiotech | Mar 22, 2023 | DMC Press Releases
22 March 2023 – DMC Biotechnologies is delighted to have been given the opportunity to pitch in front of P&G Fabric and Home Care and more than 80 of their top suppliers at the company’s Sustainability, Equality & Inclusion Supplier Summit hosted at P&G’s...
by DMCBiotech | Jan 31, 2022 | DMC Press Releases
31 January 2022 – DMC Biotechnologies, Inc. announces that strategic investors Continental Grain Company, through their venture arm Conti Ventures, and Toyobo have joined the Series B fundraising round, bringing the total raised to $39 million. DMC previously...
by DMCBiotech | Dec 2, 2021 | DMC Press Releases, News
2 December 2021 – DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD) with investment from Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures, Solvay...
by DMCBiotech | Apr 7, 2021 | DMC Press Releases, News
7 April 2021 – DMC Biotechnologies has executed an agreement with SCG Chemicals Co., Ltd to bring DMC’s L-Alanine and branched chain amino acids (BCAAs) into the ASEAN* markets. SCG was an investor in DMC’s Series A round in December 2019. Matt Lipscomb, Ph.D., CEO...
by DMCBiotech | Mar 24, 2021 | DMC Press Releases, News
24 March 2021 – DMC Co-Founder Mike Lynch has launched a web-based calculator to assess the economic feasibility of products made from fermentation. The Bioprocess Technoeconomic Analysis (TEA) tool will help users – academics, startups, funding agencies, R&D...
